Blog - Page 852 of 5752 - QualityStocks

WednesdayJan 11, 2023 8:45 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Adds to its Existing Suite of Global Patents with First Granted Patent in Canada

Lexaria has announced patent #3,093,414, its first patent in Canada, its 28th granted patent worldwide, and the first patent from its sixth patent family This patent joins the ranks of previously issued patents in Australia, India, Japan, and the EU, even as similar patent applications for skin-based delivery of patented DehydraTECH formulations remain pending in many countries In Lexaria’s 2018 study, DehydraTECH-processed CBD demonstrated almost a 1,900% increase in CBD permeability through human skin compared to a control formulation that was devoid of any commercial penetration enhancers This patent inches Lexaria closer to taking advantage of the cosmeceuticals market, projected…

TuesdayJan 10, 2023 3:01 pm

QualityStocksNewsBreaks – CubCrafters Inc. Merging High Performance, Latest Technology to Bring Unique Perspective to Access the World

CubCrafters is the leading designer and manufacturer of light-sport, experimental and Part 23 certified backcountry aircraft. “CubCrafters President and CEO Patrick Horgan recently provided an update, announcing in a Bell2Bell podcast that the U.S. Securities and Exchange Commission (‘SEC’) has qualified the company’s Reg A+ filing, clearing the way for investors to come onboard… Horgan said that the company has booked orders already awaiting fulfillment for the next two years of CubCrafters’ production schedule, and a large part of the reason for turning to public funding is to help the company grow sufficiently that it can reduce customers’ wait times,…

TuesdayJan 10, 2023 1:49 pm

QualityStocksNewsBreaks – MetAlert Inc. (MLRT) Featured on ‘Gametime with Sequire’

MetAlert (OTC: MLRT), a pioneer in location-sensitive health monitoring devices and wearable technology products for remote patient monitoring, was featured in a recent interview with Sequire Spotlight. In the program, MetAlert’s CEO Patrick Bertagna joined Host Carmel Fisher to discuss the company’s business model and goals heading into the near future. “We’re a medical device/technologies company. We cater to a specific segment of the population – people with cognitive memory disorders such as Alzheimer’s, dementia, autism, traumatic brain injury,” Bertagna said. “And most of these people can’t use conventional type of technologies. So, we’ve developed a suite of products and…

TuesdayJan 10, 2023 12:34 pm

QualityStocksNewsBreaks – CISO Global Inc. (NASDAQ: CISO) Inks Deal to Acquire South America-Based Cybersecurity Company

CISO Global (NASDAQ: CISO), an industry leader as a managed cybersecurity and compliance provider formally known as Cerberus Sentinel, has signed a definitive agreement to acquire RAN Security, a cybersecurity company headquartered in Buenos Aires, Argentina, and with offices in Chile, Peru, Bolivia, and Paraguay. According to the agreement, RAN Security will become a wholly owned subsidiary of Cerberus Sentinel. CISO Global anticipates the transaction will be finalized later this year following customary closing conditions and applicable regulatory approvals. RAN Security offers secured managed services to organizations across South America and is part of a growing network of companies acquired…

TuesdayJan 10, 2023 12:25 pm

QualityStocksNewsBreaks – Vision Energy Corp. (VENG) Incorporates Dutch Subsidiaries

Vision Energy (OTCQB: VENG), a forward-looking energy company developing carbon reduced solutions for the commercial, industrial and transportation sector, has incorporated new Dutch subsidiaries. These incorporations are designed to accommodate strategic initiatives for prospective partners, operators and launching customers for VENG’s integrated Green Energy Hub development in North Sea Port of Vlissingen, the Netherlands. According to the announcement, Vision Energy incorporated Vision Hydrogen BV as a project development company to develop, own and operate its planned Ammonia Cracking Facility. The facility will be used for back-cracking imported green ammonia to hydrogen gas as a service and will be combined with the…

TuesdayJan 10, 2023 12:06 pm

QualityStocksNewsBreaks – Data443 Risk Mitigation Inc. (ATDS) Secures VB100 Certification for Antivirus Product

Data443 (OTC: ATDS), a data security and privacy software company for “All Things Data Security,” today announced that its Data443(R) Antivirus Protection Manager(TM) has received VB100 certification. The certification is administered by Virus Bulletin, an independent organization that has tested antivirus products for more than 25 years. Joining leading organizations such as SentinelOne (NYSE: S), Fortinet (NASDAQ: FTNT), Avast Intego and Tacyon, Data443’s antivirus product is available for Microsoft Windows via desktops, laptops, virtual desktops, database engines, and Azure/AWS/GCP, along with hybrid cloud platforms and standard compute servers. “At Data443, we make every effort to help protect customers from the…

TuesdayJan 10, 2023 12:00 pm

Aditxt, Inc. (NASDAQ: ADTX) Bolsters Goal to Conduct First-In-Human Clinical Trial Evaluating ADI(TM) Tech with Formation of Adimune, Inc. Subsidiary; Appoints Industry Veteran as Subsidiary Chairman and CEO

Aditxt recently announced the formation of a U.S.-based wholly owned subsidiary, Adimune, Inc., and appointed Joachim-Friedrich Kapp, M.D., Ph.D., a 30-year veteran of the pharmaceutical industry, as its Chairman and CEO Dr. Kapp will be tasked with leading and developing the Apoptotic DNA Immunotherapy(TM) (“ADI(TM)”) technology toward clinical trials Aditxt also plans to submit a Clinical Trial Application (“CTA”) for immunotherapeutic technology drug candidate ADI(TM)-100, seeking approval for Adimune(TM) to conduct the first-in-human study in psoriasis patients, beginning in the second half of 2023 ADI(TM) is a nucleic acid-based technology platform that utilizes a novel antigen-specific approach to induce immune…

TuesdayJan 10, 2023 11:46 am

QualityStocksNewsBreaks – QSAM Biosciences Inc. (QSAM) Releases Shareholder Letter Outlining 2022 Updates, 2023 Milestone Goals

QSAM Biosciences (OTCQB: QSAM), a company developing next-generation therapeutic radiopharmaceuticals, including Samarium-153-DOTMP, or CycloSam(R), for the treatment of bone cancer and related diseases, has provided key updates and milestone goals in a shareholder letter; the letter is from QSAM Biosciences executive chair and cofounder C. Richard Piazza and CEO and cofounder Douglas Baum. The letter noted that QSAM is developing its lead therapeutic radiopharmaceutical drug candidate, CycloSam, to treat cancer that has either originated in the bone or has metastasized to the bone from the breast, prostate, lung or other organs. During 2022, CycloSam received rare pediatric disease designation for the…

TuesdayJan 10, 2023 11:34 am

QualityStocksNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Key Milestones, 2023 Business Outlook

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, today outlined key accomplishments from 2022 and provided a business update and catalysts for 2023. “Over the course of 2022, we strengthened our position as a leader in rare cannabinoid R&D, creating a unique offering as the only company that has the breadth and depth in cannabinoid drug research, development and significant manufacturing know-how,” said Eric A. Adams, InMed president and CEO. “Despite the many economic pressures affecting businesses on a global scale, including challenging capital markets, particularly in biotech, InMed…

TuesdayJan 10, 2023 11:15 am

Canada Nickel Company Inc. (TSX.V: CNC) (OTCQX: CNIKF) Is ‘One to Watch’

Canada Nickel in December 2022 announced positive drilling results from exploration at its Reid and Sothman properties The company in November 2022 announced recovery of valuable by-products from a processing pilot test, including cobalt, palladium, platinum and chromium Canada Nickel announced in November 2022 improvements to its accelerated CO2 capture process Canada Nickel announced in October 2022 it closed a secured loan with Auramet International of $10 million Canada Nickel has engaged Deutsche Bank and Scotiabank as financial advisors for the Crawford Nickel Sulphide Project Projections indicate that, by 2035, world demand for nickel will double from current levels to…

Site Search

Company Search